Novo Holdings turns to overlooked industry: Ready with millions for diagnostics firms

Kasim Kutay, CEO of Novo Holdings, is ready to put large sums of money into diagnostics companies, an otherwise neglected industry among venture funds. Unstable success rates and difficult business models keep the investors away.

Photo: Ritzau Scanpix/Niels Hougaard

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles